SCHEMBL31408356

SCHEMBL31408356

COc1cnc(-c2cc3[nH]c(CNC(=O)N4CCOCC4)cc3cc2Cl)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.39
▸ MAPK1 P28482 2/20 0.37
▸ IDH1 O75874 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MLLT1 Q03111 1/20 0.35
▸ LRRK2 Q5S007 5/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ BRD9 Q9H8M2 1/20 0.34
▸ PDK1 Q15118 1/20 0.34
▸ GAA P10253 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31408430 0.92 MAPK1 (0.37) MAPK1SMN1; SMN2MLLT1MEN1KMT2A
SCHEMBL31408279 0.91 SMN1; SMN2 (0.36) MAPK1SMN1; SMN2MLLT1LRRK2ALDH1A1
SCHEMBL31408404 0.89 LRRK2 (0.36) MAPK1SMN1; SMN2MLLT1LRRK2
SCHEMBL31408509 0.88 SMN1; SMN2 (0.34) MAPK1SMN1; SMN2MLLT1
SCHEMBL31408514 0.87 SMN1; SMN2 (0.36) MAPK1SMN1; SMN2MLLT1MEN1MAPT
SCHEMBL31408537 0.87 SMN1; SMN2 (0.36) MAPK1SMN1; SMN2MLLT1LRRK2MEN1
SCHEMBL31408376 0.87 JAK2 (0.40) MEN1KMT2A
SCHEMBL31408237 0.86 LRRK2 (0.35) MAPK1SMN1; SMN2LRRK2
SCHEMBL31408429 0.86 LRRK2 (0.35) MAPK1SMN1; SMN2LRRK2
SCHEMBL31408327 0.86 LRRK2 (0.35) MAPK1SMN1; SMN2LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049604-A1 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
Send feedback